References
Vesikari T, et al. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials. Lancet : 14 Jan 2013. Available from: URL: http://dx.doi.org/10.1016/S0140-6736%2812%2961961-8.
Snape MD, et al. The beginning of the end for serogroup B meningococcus? Lancet : [2 pages], 14 Jan 2013. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(12)62194-1.
Rights and permissions
About this article
Cite this article
Vax combating MenB shows potential for routine immunisation. Reactions Weekly 1436, 4 (2013). https://doi.org/10.1007/s40278-013-0864-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-0864-4